Veterinary Medicine Information website

Phenoxypen WSP

Authorised
  • Phenoxymethylpenicillin potassium
Download as PDF

Product identification

Medicine name:
Phenoxypen WSP
Active substance:
  • Phenoxymethylpenicillin potassium
Target species:
  • Chicken
Route of administration:
  • In drinking water use
  • Oral use

Product details

Active substance and strength:
  • Phenoxymethylpenicillin potassium
    325.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        2
        day
      • Eggs
        0
        day
  • Oral use
    • Chicken
      • Meat and offal
        2
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CE02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • White polypropylene bucket provided with a polypropylene lid containing 5 kg of product.
  • White polypropylene bucket provided with a polypropylene lid containing 2.5 kg of product.
  • Securitainer: white PP cylin drical container, with white HDPE/LDPE closure, with thumb tab for opening, containing 1000 g (1875 ml) of product.
  • Composite can: three layered rectangular container, which co nsists of a cardboard base with an inner lining of aluminium paper and with label on the outside containing 1 kg of product.
  • White polypropylene bucket provided with a polypropylene lid containing 1 kg of product.
  • Securitainer: white PP cylin drical container, with white HDPE/LDPE closure, with thumb tab for opening, containing 250 g (650 ml) of product.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10333
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0121/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 25/01/2022
Download